Sell RIM!: Against ...
Health Care: Drugs
Cytokinetics Inc. (CYTK: NASDAQ)
$0.88 -0.02 | -2.17%
06/04/12 - 03:59 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 18.83M | 17.51M | 25.56M | 41.82M |
| Receivables | 14.00K | 46.00K | 189.00K | 261.00K |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 2.36M | 0.00 |
| Total Current Assets | 51.14M | 73.50M | 116.92M | 58.91M |
| Property, Plant & Equipment, Gross | 24.10M | 24.10M | 23.66M | 25.53M |
| Accumulated Depreciation & Depletion | 22.79M | 21.78M | 19.95M | 20.44M |
| Property, Plant & Equipment, Net | 1.31M | 2.32M | 3.71M | 5.09M |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 323.00K | 2.17M | 1.96M | 23.46M |
| Total Non-Current Assets | 1.63M | 4.49M | 5.68M | 28.54M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 52.77M | 77.99M | 122.60M | 87.45M |
| Accounts Payable | 1.21M | 1.12M | 1.68M | 1.38M |
| Short Term Debt | 152.00K | 833.00K | 1.62M | 2.02M |
| Other Current Liabilities | 0.00 | 0.00 | 10.20M | 0.00 |
| Total Current Liabilities | 4.59M | 7.32M | 20.19M | 22.88M |
| Long Term Debt | 0.00 | 152.00K | 985.00K | 2.62M |
| Deferred Income Taxes | 3.00K | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 12.20M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 3.00K | 152.00K | 985.00K | 14.81M |
| Total Liabilities | 4.60M | 7.48M | 21.17M | 37.69M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 48.18M | 70.52M | 101.43M | 49.77M |
| Common Par | 75.00K | 67.00K | 61.00K | 50.00K |
| Additional Paid In Capital | 456.61M | 431.10M | 412.73M | 385.60M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -408.51M | -360.65M | -311.36M | -335.91M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 3.00K | -4.00K | 1.00K | 18.00K |
| Total Capitalization | 48.18M | 70.67M | 102.41M | 52.38M |
| Total Equity | 48.18M | 70.52M | 101.43M | 49.77M |
| Total Liabilities & Stock Equity | 52.77M | 77.99M | 122.60M | 87.45M |
| Total Common Shares Outstanding | 74.92M | 66.91M | 61.28M | 49.94M |
| Preferred Shares | 8.07K | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 70.80M | 64.16M | 57.39M | 49.39M |
| Diluted Weighted Shares Outstanding | 70.80M | 64.16M | 57.96M | 49.39M |
| Number of Employees | 79 | 105 | 111 | 110 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with CYTK
- Portfolio NameUser Type
- Contributor$5 Stocks That Analysts Exp...
- UserBlue OAK
- UserDaveofDuke1111
- UserASCO 2010 Part 2
- ContributorBarron's Insider Purchases ...
- UserASCO 2009 Nymph's Watch List.
- UserHot Biotech Stocks II
- UserLet's Go Channeling
- UserDizziMage's Port
- Usermileslb Fidelity IRA
Latest CYTK Headlines from TheStreet
- Cytokinetics CEO Discusses Q3 2010 Results - Earnings Call Transcript 10.28.10 | 11:10 pm
- $5 Stocks That Analysts Expect to Double 08.02.10 | 06:08 am
- Cytokinetics Inc. Q2 2010 Earnings Call Transcript 07.29.10 | 03:07 am
- Cytokinetics Ends Cancer Deal With GlaxoSmithKline 12.09.09 | 04:12 pm
- Movers Roundup: Manitowoc, Symantec 10.29.09 | 02:10 pm
- Cytokinetics Shares Fall On Drug Development Delay 10.29.09 | 12:10 pm
- Harmonic, SkyPeople: Midday Volume Plays 10.29.09 | 12:10 pm
- High Times
09.29.09 | 10:09 am - Cytokinetics: Pump Up The Volume 09.25.09 | 03:09 pm
- Optimer Soars on Antibiotic Data 11.11.08 | 12:11 pm
Press Releases for CYTK
Partner Headlines for CYTK
- Rodman & Renshaw Reiterates Cytokinetics Market Outperform, $4 PT - Benzinga 11.01.11 | 04:11 pm
- 16 Small Caps With Cash to Cover 1+ Years of Operating Expenses - Seeking Alpha 04.20.11 | 04:04 am
- Cytokinetics Up 9% (CYTK) - Benzinga 04.12.11 | 09:04 am
- Cytokinetics: Most Recent Victim of Unjustified Biotech Sell-Off - Seeking Alpha 12.19.10 | 07:12 am
- UPDATE 1-Cytokinetics' Lou Gehrig's drug gets orphan status - Reuters 03.10.10 | 09:03 am
